LRRK2 and Parkinson disease: GCase activity has been shown to be reduced also in peripheral monocyte extracts from PD patients without mutations in GBA111,12 and in PD brains13, overall suggesting that alterations of GCase activity may be a common underlying feature of PD, similar to what has been proposed for changes in LRRK2 kinase activity.